miR ‐145 is a potential biomarker for predicting clinical outcome in glioblastomas
In this study, a retrospective study was conducted in 86 cases of patients with glioblastoma after neurosurgery combined with chemoradiotherapy, and 36 cases with traumatic brain injury. Our results showed that miR‐145 was significantly lower in glioblastoma tissues th an that in normal brain tissue (P < 0.05). Furthermore, miR‐145 was lower in patients with lower Karnofsky Performance Scale (KPS) scores than in patients with higher KPS scores (P < 0.05). Cox Regression analysis showed that low miR‐145 expression was associated with poor patient survival (P < 0.05). These data suggested that patients with glioblastoma with lower miR‐145 expression are prone to shorter overall survival.
Source: Journal of Cellular Biochemistry - Category: Biochemistry Authors: Lei Shi,
Bin Wang,
Xiaoyan Gu,
Shuguang Zhang,
Xiaoliang Li,
Haifeng Zhu Tags: RESEARCH ARTICLE Source Type: research
More News: Biochemistry | Brain | Brain Tumor | Cold Sores | Gene Therapy | Genetics | Glioma | Herpes | Neurology | Neurosurgery | Study